IBA and NorthStar Medical Radioisotopes Sign Contract for Rhodotron® Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)

NEXT STORY
180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 International Dupuytren Symposium 
PREV STORY
EMA Provides Regulatory Path for Pediatric Label Extension for NexoBrid
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TESARO Announces Approval of VARUBY® (Oral Rolapitant Tablets) by European Commission

VARUBY provides protection for delayed chemotherapy-induced nausea and vomiting (CINV) with a single dose ...

author_avatar
NASDAQ Market News

XBiotech to Provide Third Quarter 2016 Business Update on November 15

AUSTIN, Texas, Nov. 10, 2016 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of True ...

author_avatar
NASDAQ Market News

Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017

$3.9 Billion All Cash Proposed Tender Offer by Novartis European Approval of Lutetium Lu ...

author_avatar
NASDAQ Market News